Prestige Consumer Healthcare Return on Investment 2010-2025 | PBH

Current and historical return on investment (ROI) values for Prestige Consumer Healthcare (PBH) over the last 10 years.
Prestige Consumer Healthcare ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-03-31 $0.34B $2.85B 12.01%
2024-12-31 $0.33B $2.78B 11.87%
2024-09-30 $0.33B $2.78B 11.67%
2024-06-30 $0.33B $2.77B 11.80%
2024-03-31 $0.34B $2.78B 12.24%
2023-12-31 $-0.02B $2.80B -0.75%
2023-09-30 $-0.02B $2.80B -0.73%
2023-06-30 $-0.03B $2.80B -0.85%
2023-03-31 $-0.02B $2.80B -0.76%
2022-12-31 $0.34B $3.11B 10.90%
2022-09-30 $0.33B $3.06B 10.82%
2022-06-30 $0.33B $3.06B 10.66%
2022-03-31 $0.33B $3.06B 10.87%
2021-12-31 $0.32B $3.05B 10.87%
2021-09-30 $0.31B $3.06B 10.69%
2021-06-30 $0.31B $2.97B 10.69%
2021-03-31 $0.30B $2.85B 10.41%
2020-12-31 $0.30B $2.88B 10.46%
2020-09-30 $0.30B $2.84B 10.58%
2020-06-30 $0.30B $2.85B 10.41%
2020-03-31 $0.29B $2.91B 10.07%
2019-12-31 $0.06B $2.86B 2.19%
2019-09-30 $0.07B $2.87B 2.22%
2019-06-30 $0.07B $2.88B 2.24%
2019-03-31 $0.07B $2.89B 2.23%
2018-12-31 $0.20B $3.08B 6.34%
2018-09-30 $0.20B $3.09B 6.43%
2018-06-30 $0.21B $3.16B 6.64%
2018-03-31 $0.22B $3.17B 6.95%
2017-12-31 $0.29B $3.27B 9.51%
2017-09-30 $0.28B $2.99B 9.87%
2017-06-30 $0.27B $3.00B 10.37%
2017-03-31 $0.21B $3.02B 8.37%
2016-12-31 $0.22B $2.22B 9.48%
2016-09-30 $0.21B $2.25B 9.27%
2016-06-30 $0.21B $2.32B 9.32%
2016-03-31 $0.26B $2.37B 11.78%
2015-12-31 $0.26B $2.17B 11.84%
2015-09-30 $0.25B $2.16B 11.46%
2015-06-30 $0.23B $2.17B 10.27%
2015-03-31 $0.21B $2.19B 10.06%
2014-12-31 $0.19B $2.25B 10.13%
2014-09-30 $0.18B $2.28B 10.21%
2014-06-30 $0.18B $1.56B 11.94%
2014-03-31 $0.19B $1.50B 12.54%
2013-12-31 $0.19B $1.53B 12.98%
2013-09-30 $0.20B $1.52B 13.60%
2013-06-30 $0.20B $1.45B 13.40%
2013-03-31 $0.19B $1.45B 12.93%
2012-12-31 $0.17B $1.46B 10.97%
2012-09-30 $0.14B $1.52B 10.54%
2012-06-30 $0.12B $1.52B 10.19%
2012-03-31 $0.10B $1.53B 10.20%
2011-12-31 $0.10B $0.83B 11.78%
2011-09-30 $0.09B $0.84B 10.39%
2011-06-30 $0.08B $0.84B 10.40%
2011-03-31 $0.08B $0.85B 10.33%
2010-12-31 $0.08B $0.86B 10.88%
2010-09-30 $0.09B $0.64B 13.38%
2010-06-30 $0.08B $0.63B 12.72%
2010-03-31 $0.08B $0.62B 12.28%
2009-12-31 $-0.17B $0.64B -26.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.123B $1.138B
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.811B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00